THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at ...

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...

Armah Sports Group is a leading operator in Saudi Arabia, with twelve locations across two brands and additional concepts in developmentCLMBRs are being installed in three of Armah Sports Group's ...

DALLAS, TX / ACCESSWIRE / November 19, 2024 / Adnexus Biotechnologies Inc. is pleased to announce the appointment of Dr. Hiroshi Ohrui to its Scientific Advisory Board. Dr. Ohrui is a distinguished ...

As previously communicated, the planned Phase IIa study will be conducted in two parts. Part 1 aims to establish dosage levels and safety of sevuparin through single doses in 25-30 patients with ...

PHIOGEN, a biotech company developing live biotherapeutic products (LBPs) for drug-resistant and recurrent bacterial infections, is collaborating with patient research and advocacy organization Live ...

Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women's health, today announces a $10.4 million strategic investment from the Bill & Melinda Gates Foundation ...

Australia’s Human Research Ethics Committees (HREC) cleared first-in-human study of drug candidate PLL001 PLL001 aims at restoring microbiome and stopping gut from leaking to treat root cause of ALS, ...

Cytomos, an Edinburgh-based biotechnology company, has raised £5 million to scale up production of its unique cell analysis technology. The oversubscribed funding round was led by existing investors ...

PALO ALTO, CA / ACCESSWIRE / November 19, 2024 / Bioz, Inc., a driving force in AI-enhanced citation tracking, is pleased to announce a new partnership with DNA Polymerase Technology. By integrating ...

Month figures/ConferenceFormycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences 19.11.2024 / 06:30 CET/CESTThe issuer is ...

ExpansionSiegfried opens new global R&D Center for Drug Substances in Evionnaz 19.11.2024 / 07:03 CET/CESTMedia ReleaseZofingen, November 19, 2024Siegfried (SIX: SFZN), a leading global Contract ...